MedPath

NOVO-POXIDE 25MG

NOVO-POXIDE 25MG

Discontinued
DIN Number

00020931

Drug Class

Human

Market Date

Dec 31, 1970

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00020931
AIG Number0100613002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA02 CHLORDIAZEPOXIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CHLORDIAZEPOXIDE HYDROCHLORIDEActive
Strength: 25 MG / CAP
Monograph: CHLORDIAZEPOXIDE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.